Showing results (11-20 of 25) with videos related to
Sort By:
Pageof 3
Journal of Immunology (Baltimore, Md. : 1950)|April 25, 2012
Tumor-expressed inducible nitric oxide synthase controls induction of functional myeloid-derived suppressor cells through modulation of vascular endothelial growth factor releasePadmini Jayaraman, Falguni Parikh, Esther Lopez-Rivera, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 13, 2018
Peptide Vaccine Formulation Controls the Duration of Antigen Presentation and Magnitude of Tumor-Specific CD8+ T Cell ResponseHiep Khong, Annika Volmari, Meenu Sharma, et al.Nature Medicine|May 27, 2014
Generation of a new therapeutic peptide that depletes myeloid-derived suppressor cells in tumor-bearing miceHong Qin, Beatrisa Lerman, Ippei Sakamaki, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 15, 2010
Inhibition of p-STAT3 enhances IFN-alpha efficacy against metastatic melanoma in a murine modelLing-Yuan Kong, Alexander Gelbard, Jun Wei, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 30, 2017
Multifaceted Role of BTLA in the Control of CD8+ T-cell Fate after Antigen EncounterKrit Ritthipichai, Cara L Haymaker, Melisa Martinez, et al.Molecular Cancer Therapeutics|December 28, 2020
The Glutaminase Inhibitor CB-839 (Telaglenastat) Enhances the Antimelanoma Activity of T-Cell-Mediated ImmunotherapiesSruthy Varghese, Snigdha Pramanik, Leila J Williams, et al.The Journal of Clinical Investigation|February 27, 2018
Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapyYared Hailemichael, Amber Woods, Tihui Fu, et al.Nature Communications|August 12, 2017
Absence of Grail promotes CD8+ T cell anti-tumour activityCara Haymaker, Yi Yang, Junmei Wang, et al.Nature Communications|November 14, 2017
Intratumoral CD40 activation and checkpoint blockade induces T cell-mediated eradication of melanoma in the brainManisha Singh, Christina Vianden, Mark J Cantwell, et al.Nature Medicine|March 5, 2013
Persistent antigen at vaccination sites induces tumor-specific CD8⁺ T cell sequestration, dysfunction and deletionYared Hailemichael, Zhimin Dai, Nina Jaffarzad, et al.Pageof 3